// App-Quantinova.ai

614 : Comparison of Reduced Intensity Conditioning - Allogeneic HCT and Autologous HCT for Elderly Patients with Acute Lymphoblastic Leukemia. an Analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Researchers

Presenter

  • Sebastian Giebel Sr

Principal Investigators

  • Myriam Labopin

  • Mohamed Houhou

  • Denis Caillot

  • Jrgen Finke Sr

  • Didier Blaise

  • Nathalie Fegueux

  • Mark Edward Ethell

  • Jan J. Cornelissen

  • Edouard Forcade

  • Ibrahim Yakoub-Agha

  • Federico Lussana

  • Johan Maertens

  • Jean-Henri Bourhis

  • Pavel Jindra

  • Norbert Claude Gorin

  • Arnon Nagler

  • Mohamad Mohty

Medical Centers

  • Department of Bone Marrow Transplantation and Hematology-Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland

  • Sorbonne Universites, UPMC Univ Paris 06, INSERM, Centre de Recherche Saint-Antoine (CRSA), Paris, France

  • Hematology Department, Hopital Saint Antoine, Service dHematologie et Therapie Cellulaire, Paris, France

  • EBMT-ADWP, Paris, France

  • INSERM U & University Pierre et Marie Curie, Paris, France

  • ALWP of the EBMT Paris office, Paris, France

  • Department of Surgery, Saint-Antoine Hospital, Paris, France

  • CHU de Dijon, Service d'Hématologie, Dijon, France

  • University of Freiburg, Freiburg, Germany, Dept. of Hematology, Oncology and Stem Cell Transplantation,, Freiburg, Germany

  • Institut Paoli-Calmettes, Marseille, France

  • CHU Lapeyronie,Département d`Hématologie Clinique, Montpellier, France

  • Royal Marsden Hospital, Surrey, United Kingdom

  • Department of Hematology, Erasmus MC Cancer Insitute, Rotterdam, Netherlands

  • CHU Bordeaux, Hospital Haut-Leveque, Pessac, FRA

  • Univ Lille, CHU de Lille, INFINITE, INSERM U1286, 59000 Lille, LILLE, France

  • Hematology and Bone Marrow Transplant Unit, ASST Papa Giovanni XXIII, Bergamo, Please Choose A State, Italy

  • University Hospital Gasthuisberg, Leuven, Belgium

  • Gustave Roussy, Villejuif, France

  • GPK University Hospital, Plzen, Czech Republic

  • Hospital Saint Antoine, Paris, France

  • Leukemia Working Party of EBMT, Paris, France,

  • Director Division of Hematology Chaim Sheba Medical Center, Tel Hashomer, Israel

  • Saint Antoine Hospital, paris, France

  • EBMT Acute Leukemia Working Party and Registry, Paris, France

Locations

  • Poland

  • France

  • Germany

  • United Kingdom

  • Netherlands

  • Italy

  • Belgium

  • Czech Republic

  • Israel

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Blood/haematological Diseases

Disease

  • Acute lymphoblastic leukemia

  • Acute Leukemia

Biomarkers

  • Breakpoint Cluster Region

  • Ph chromosome

  • Hematocrit

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • fludarabine tablet

  • Busulfex

  • Allopurinol

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A